Affinity DataEC50: 120nMAssay Description:The analyses of antiviral activities of UAWJ9-36-1 (A, C) and UAWJ9-36-3 (B, D) against SARS-CoV-2 in immunofluorescence assay was carried out in Ver...More data for this Ligand-Target Pair
Affinity DataEC50: 350nMAssay Description:The analyses of antiviral activities of UAWJ9-36-1 (A, C) and UAWJ9-36-3 (B, D) against SARS-CoV-2 in immunofluorescence assay was carried out in Ver...More data for this Ligand-Target Pair
Affinity DataEC50: 440nMAssay Description:CPE assay was carried out in Huh-7 cells in the presence or absence of P-glycoprotein inhibitor CP-100356.More data for this Ligand-Target Pair
Affinity DataEC50: 480nMAssay Description:The analyses of antiviral activities of UAWJ9-36-1 (A, C) and UAWJ9-36-3 (B, D) against SARS-CoV-2 in immunofluorescence assay was carried out in Ver...More data for this Ligand-Target Pair
Affinity DataEC50: 540nMAssay Description:CPE assay was carried out in Huh-7 cells in the presence or absence of P-glycoprotein inhibitor CP-100356.More data for this Ligand-Target Pair
Affinity DataEC50: 770nMAssay Description:CPE assay was carried out in Huh-7 cells in the presence or absence of P-glycoprotein inhibitor CP-100356.More data for this Ligand-Target Pair
Affinity DataEC50: 1.27E+3nMAssay Description:The analyses of antiviral activities of UAWJ9-36-1 (A, C) and UAWJ9-36-3 (B, D) against SARS-CoV-2 in immunofluorescence assay was carried out in Ver...More data for this Ligand-Target Pair
Affinity DataEC50: 1.31E+3nMAssay Description:The analyses of antiviral activities of UAWJ9-36-1 (A, C) and UAWJ9-36-3 (B, D) against SARS-CoV-2 in immunofluorescence assay was carried out in Ver...More data for this Ligand-Target Pair
Affinity DataEC50: 3.68E+3nMAssay Description:The analyses of antiviral activities of UAWJ9-36-1 (A, C) and UAWJ9-36-3 (B, D) against SARS-CoV-2 in immunofluorescence assay was carried out in Ver...More data for this Ligand-Target Pair
